IMMvention is developing therapies that inhibit multiple inflammasome pathways that result in increased cytokine production that is at the root cause of some of the following diseases.

Biotechnology

IMMvention Therapeutix

The Durham office likely serves as a strategic hub for governance and oversight activities within the organization.

Durham

IMMvention Therapeutix's headquarters in Durham, NC, United States

Anil Goyal

J. David Becherer

Marilyn Thompson

Tom Barta

Joseph Vacca

Jenny Ting

Niti Goel

This department provides expert guidance and recommendations to support decision-making and strategic initiatives.

Advisory Services

This department oversees strategic direction and organizational governance.

Governance Board

This department oversees the strategic direction and overall operations of the organization.

Executive Management

This department focuses on the design and development of pharmaceutical compounds through the principles of medicinal chemistry.

Medicinal Chemistry

This department oversees and coordinates various programs and alliances within the organization.

Program Management

The Research and Development Team at IMMvention Therapeutix is dedicated to innovating and advancing therapies that target multiple inflammasome pathways to reduce cytokine production. Comprising roles from Senior Scientist to Head of Chemistry, the team collaborates to research, design, and develop new therapeutic agents aimed at treating diseases driven by excessive cytokine activity.

IMMvention Therapeutix

Org chart

Board & advisors

Teams

Advisory Services

Governance Board

Executive Management

Medicinal Chemistry

Program Management

Research and Development Team

Offices

IMMvention Therapeutix

Org chart

Board & advisors

Teams

Advisory Services

Governance Board

Executive Management

Medicinal Chemistry

Program Management

Research and Development Team

Offices

Related companies